rs137852428
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PS4PS2PP1_StrongPP3PP4_Moderate
This summary comes from the ClinGen Evidence Repository: The c.1834C>T (p.Arg612Cys) variant is present in 3 hemizygotes in gnomAD v2.1.1, so PM2_Supporting in not met. The REVEL score of 0.88 which meets PP3 criteria (threshold >0.6). Thirty-two patients were reported with mild-moderate hemophilia A in a single publication and over 100 individuals were identified in the My Life Our Future Cohort, meeting F8 phenotype criteria for PP4_Moderate and PS4_Very strong (PMID:18691168, 29296726). This variant has been associated with mostly mild, but also moderate and severe, hemophilia A with and without inhibitors to factor replacement therapies. This may be in part because the variant has also been associated with discrepant factor VIII activity levels, with chromogenic assays (two-stage) being 2-fold lower than one stage assays (EAHAD database; PMID:32232366). The variant has been reported to segregate with hemophilia A in greater than 6 meioses across two families (PP1_Strong; PMID:9292523). This variant has also been found to have at least one de novo occurrence in the mother of a proband, where the proband was found to have the unaffected maternal grandfather's allele via haplotype analysis (PS2; PMID:9292523). Additionally, this variant has been reported in patients with and without a history of inhibitors to factor replacement products (EAHAD database). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F8: PS2, PS4_Very strong, PP1_Strong, PP3 and PP4_Moderate. LINK:https://erepo.genome.network/evrepo/ui/classification/CA255129/MONDO:0010602/071
Frequency
Consequence
NM_000132.4 missense
Scores
Clinical Significance
Conservation
Publications
- hemophilia AInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- mild hemophilia AInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- moderately severe hemophilia AInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- severe hemophilia AInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- symptomatic form of hemophilia A in female carriersInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000132.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| F8 | NM_000132.4 | MANE Select | c.1834C>T | p.Arg612Cys | missense | Exon 12 of 26 | NP_000123.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| F8 | ENST00000360256.9 | TSL:1 MANE Select | c.1834C>T | p.Arg612Cys | missense | Exon 12 of 26 | ENSP00000353393.4 | ||
| F8 | ENST00000647125.1 | n.*1710C>T | non_coding_transcript_exon | Exon 13 of 14 | ENSP00000496062.1 | ||||
| F8 | ENST00000647125.1 | n.*1710C>T | 3_prime_UTR | Exon 13 of 14 | ENSP00000496062.1 |
Frequencies
GnomAD3 genomes AF: 0.00000894 AC: 1AN: 111816Hom.: 0 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.0000218 AC: 4AN: 183438 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.0000100 AC: 11AN: 1097783Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 4AN XY: 363141 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000894 AC: 1AN: 111816Hom.: 0 Cov.: 22 AF XY: 0.0000294 AC XY: 1AN XY: 33994 show subpopulations
ClinVar
ClinVar submissions as Germline
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at